Latest filing published 31 Jul 2026 for 리센스메디컬.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -72.8%Entry ₩8,340 · Close at T+90 ₩2,268
- -63.7%Entry ₩24,200 · Close 06 Oct 2026 ₩8,790
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Bnk투자증권: trading record in brief
Filings by Bnk투자증권 span 3 companies, the busiest being 리센스메디컬, 보원케미칼 and 비엔케이제2호기업인수목적. Between 17 March 2026 and 31 July 2026, the trades on record add up to 6 filings.
Market trades split into 2 purchases and 3 sales. The totals do not cover 5 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 31 July 2026, reports a transaction in 리센스메디컬. The last insider purchase was made public on 10 April 2026, 212 days ago. Typically, a trade is published a median of 7 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Companies and markets linked to Bnk투자증권
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0DART
- 288,235 sharesKRXDART:20260427000169
- 634,795 sharesKRXDART:20260410000074Canonical exit: 2 Jul 2026 (T+90)
- 581,355 sharesKRXDART:20260407002876Canonical exit: 29 Jun 2026 (T+90)
- ShareKRXDART:20260317000453
- 1,000,000 sharesKRXDART:20260317000376
6 of 6 declarations